Aortic biological valve prosthesis in patients younger than 65 years of age: transition to a flexible age limit?
Authors:
Open Access
- 3 January 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 16 (4) , 501-507
Abstract
Guidelines proposed bioprosthesis implantation for aortic valve disease if the patients were at least 65 years old at the time of surgery, with a trend towards even younger patients in recent years. Considering the adverse effects of lifetime anticoagulation, new biological valves (less prone to degeneration) and new technologies may lead patients and surgeons to different choices. Therefore, it is interesting to analyse the results of aortic bioprosthetic valve replacement in patients aged <65 years at the time of surgery. From January 2000 to December 2010, 84 patients aged <65 years at the time of surgery had undergone an aortic bio-prosthetic valve replacement. A mid-term follow-up [(FU) mean FU time: 54.4 ± 39.2 months] was done in August 2011 in all patients (FU completeness: 100%). Results were compared with patients who had a mechanical prosthetic aortic valve replacement during the same period. The reoperation rate for structural valve degeneration (SVD) of bioprostheses was 6% and occurred exclusively among patients <56 years. Contraindications for anticoagulation determined the choice of a bioprosthesis among 83% of these patients. The personal preference to avoid anticoagulation was the leading cause in 68% of the older patients (56–65 years). Neurological complications occurred more frequently in the mechanical control group. Reoperations for SVD after bioprosthesis implantation occurred exclusively among younger patients (<56 years), not suitable for systemic anticoagulation. Previous studies, together with our experience, are in favour of an age limit between 56 and 60 years, taking into consideration alternative transcatheter approaches to SVD treatment.Keywords
This publication has 17 references indexed in Scilit:
- Guidelines on the management of valvular heart disease (version 2012)European Journal of Cardio-Thoracic Surgery, 2012
- Prosthetic valve selection for middle-aged patients with aortic stenosisNature Reviews Cardiology, 2010
- Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter studyThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Microsimulation and clinical outcomes analysis support a lower age threshold for use of biological valvesHeart, 2010
- Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?The Annals of Thoracic Surgery, 2010
- Transcatheter valve-in-valve implantation for the treatment of stentless aortic valve dysfunctionThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Choice of Prosthetic Heart Valve in AdultsJACC, 2010
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 2006
- Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of CardiologyEuropean Heart Journal, 2006
- Tissue characterization and calcification potential of commercial bioprosthetic heart valvesThe Annals of Thoracic Surgery, 2001